Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03876093

Epilepsy-related Brain Tumors Register

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Fondation Hôpital Saint-Joseph · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Epilepsy is defined by a cerebral disorder characterized by a lasting predisposition to generate epileptic seizures and by the neurobiological, cognitive, psychological and social consequences of this affection. The definition of epilepsy requires the occurrence of at least one epileptic seizure. 1% of the population suffers from epilepsy. The most common causes are genetic and vascular, 10% of epileptic syndromes are caused by a tumor. The incidence of brain tumors in people with epilepsy is approximately 4%. Among patients with brain tumor (s), the frequency of epilepsy is 30% or more depending on type of tumeur. 30-50% of brain tumors are revealed by an epileptic seizure and 10 to 30% of patients with brain tumor (s) will develop seizures during their evolution. The main objective is to evaluate the frequency of epileptic seizures according to the type of brain tumor.

Conditions

Timeline

Start date
2018-10-01
Primary completion
2023-12-31
Completion
2024-06-30
First posted
2019-03-15
Last updated
2021-04-27

Source: ClinicalTrials.gov record NCT03876093. Inclusion in this directory is not an endorsement.